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Introduction
Infective endocarditis (IE) represents the fourth leading cause
of life-threatening infectious disease in the US [1]. Despite
advances in diagnosis and treatment, IE still carries a high
morbidity and mortality rate [2]. Factors that are strongly
associated with poor outcome are the presence of uncon-
trolled infection or development of congestive heart failure
that may require transfer to the ICU. When complications
APACHE = Acute Physiology and Chronic Health Evaluation; AV = atrioventricular; CPR = cardiopulmonary resuscitation; ICU = intensive care
unit; IE = infective endocarditis; NVE = native valve endocarditis; PVE = prosthetic valve endocarditis; WBC = white blood cell count.
Abstract
Aim:  To study incidence, clinical course and prognostic factors in patients admitted to medical
intensive care units (ICUs) because of a complicated course of infective endocarditis.
Method: This was a retrospective multicenter observational study of 4106 patients admitted to four
medical ICUs in one tertiary hospital and one university hospital between 1994 and 1999.
Results: Infective endocarditis was identified in 33 (0.8%) patients. Of these, 26 were male, mean age
was 59 ± 12 and APACHE-III score was 75 ± 31. Reasons for transfer to the ICU were congestive
heart failure in 64%, septic shock in 21%, neurological deterioration in 15% and cardiopulmonary
resuscitation in 9%. Inotropes or vasoconstrictors were required in 73% and multiorgan failure
developed in 64% of the patients. Prosthetic valve endocarditis was present in 21%. Gram-positive
cocci were found in 96% of all positive cultures; cultures were negative in 27% of the patients.
Transthoracic echocardiograms were diagnostic in only 33% and transesophageal studies were
required in 91% to confirm diagnosis or fully to delineate the extent of disease. Surgical intervention
was performed in 60% of the patients, and the remaining 40% were only treated medically. The
APACHE-III score on admission did not differ statistically between the two groups (69 ± 30 versus
84 ± 34, P = 0.17). In-patient mortality was 84% in patients treated medically, and 35% in surgically
treated patients. Using multivariate analysis, acute renal failure on admission was identified as the
independent single predictor for in-patient death (OR 5, 95% CI 1.04–24.03, P = 0.04).
Conclusion: The prognosis for patients with infective endocarditis requiring admission to a medical ICU
is serious. Nevertheless, the data suggest that surgical intervention may be successfully performed in a
substantial number of patients despite the presence of severe shock and occurrence of multiorgan failure.
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have developed, results of medical therapy are unsatisfactory,
with mortality in up to 90% of cases [3,4]. Although several
studies have suggested that a more aggressive surgical
approach may improve prognosis, the tendency to postpone
surgery in the hope of improving the hemodynamic status and
of controlling the septic condition persists [5]. Systematic
data on this subject are not available, so assessments were
made of incidence, clinical course and outcome of patients
admitted to medical intensive care units (ICUs) because of a
complicated course of IE.
Materials and methods
Subjects
We reviewed ICU records of all patients with the diagnosis of
IE who were admitted to four medical ICUs in Vienna
between January 1994 and January 1999. Patients were
selected for the study if they fulfilled the Duke criteria for defi-
nite endocarditis published in detail elsewhere [6]. Pathologi-
cal criteria included either demonstrable microorganisms or
pathological lesions compatible with active endocarditis. For
clinical diagnosis of endocarditis, two major criteria, one
major and three minor criteria or five minor criteria were
required. Major criteria included positive blood cultures
(typical microorganisms or persistently positive blood cul-
tures) and evidence of endocardial involvement (positive
echocardiogram for IE or new valvular regurgitation). Minor
criteria included presence of predisposing cardiac disease,
intravenous drug use, fever, vascular phenomena, immunolog-
ical phenomena, microbiological evidence, and echocardio-
graphic criteria not fulfilling the major criteria. The routine
microbiologic screening also included fastidious organisms,
anaerobes, fungi, and organisms from the HACEK group,
whereas screening for bartonella, legionella and brucella was
not routinely performed.
Patients who were preoperatively admitted to the ICU
because of scheduled cardiac surgery as well as patients
transferred to the ICU after cardiac surgery were excluded.
After having applied the above-mentioned criteria to all avail-
able patient charts, 33 patients with the definite diagnosis of
IE were identified.
Clinical data
Clinical data were obtained from a review of the patients’
medical records. This review included demographic data,
presence of inclusion and exclusion criteria, APACHE-III
score and Glasgow coma score on ICU admission, duration
of illness and duration of ICU-stay, multiple laboratory data,
echocardiographic findings, microbiological findings, timing
and type of surgery. Heart failure was defined by the pres-
ence of hypotension (systolic arterial pressure <90 mmHg
and/or need for inotropic or vasopressor therapy) and pul-
monary congestion consistent with edema on a chest X-ray.
Septic shock was defined as hypotension (systolic arterial
pressure <90 mmHg and/or need for vasopressor therapy),
fever (>38.3°C) or hypothermia (<35.5°C), tachycardia
(>90 beats/min) and tachypnoea (>20/min). Renal failure
was defined as oliguria (<20 ml/h) accompanied by an
increase in serum creatinine of at least 44 µmol/L above
baseline and/or severe renal dysfunction requiring extracor-
poreal renal support. Respiratory failure was defined as a
PaO2/FiO2 less than 200 while breathing spontaneously
and/or the need for mechanical ventilation. Multiorgan failure
was defined as more than three points of Goris score [7].
Major embolic events were defined by both clinical symptoms
(sudden neurologic deficit, ischemia in the peripheral circula-
tion) and definitive findings on diagnostic imaging procedures
(computed tomography of the brain; coronary angiogram;
sonography or computed tomography of the abdomen,
sonography of peripheral arteries).
Echocardiography
Transthoracic echocardiography and transesophageal
echocardiography were performed using one of three avail-
able systems (VINGMED 800, DIASONICS, Horten, Norway;
ACUSON 2500, Mountain View, CA; SONOS 5500, Hewlett
Packard, Andover, MA). Transthoracic echocardiography was
performed immediately before transesophageal echocardiog-
raphy in 31/33 patients. Besides all standard views, multiple
additional views were required in many patients to delineate
the full extent of cardiac involvement. Valvular vegetations
were defined as soft mobile masses attached to the endo-
cardium distinct in echogenicity from the cardiac valves with
motion independent of cardiac structures. Valvular regurgita-
tion was assessed using standard criteria [8]. Abscess for-
mation was diagnosed by presence of an echo-free space in
the paravalvular region or abnormal paravalvular echogenicity
measuring more than 10 mm [9].
Statistical analysis
Data are shown as percentage or mean ± standard deviation.
The chi-square test and Fisher’s exact test were used in
cases of categorical variables. Univariate analysis was used
to determine risk factors for ICU-mortality. Variables sug-
gested by the univariate analysis (P < 0.10) were entered into
a forward stepwise multiple logistic regression analysis
model. A P-value <0.05 was considered significant.
Results
Clinical characteristics
Among 4106 patients hospitalized in four medical ICUs
during the 4-year study period, 33 (0.8%) patients, 26 men
and seven women were admitted because of a complicated
course of IE. Two of these patients had a previous episode of
IE. In 18 (55%) patients, presence of IE was already estab-
lished on admission, whereas 15 (45%) cases were newly
diagnosed after transfer to the ICU. Demographic character-
istics, clinical features and laboratory data within 24 h after
ICU admission are presented in Table 1. Reasons for transfer
to the ICU of the 33 patients were: congestive heart failure in
21 (64%) cases; septic shock in seven (21%) cases; neuro-
logical deterioration in five (15%) cases and in-patient car-diopulmonary resuscitation in three (9%) cases. Thirteen
(39%) patients had acute renal failure, 26 (79%) patients
were mechanically ventilated, and 24 (73%) patients required
administration of positive inotropes or vasoconstrictors [epi-
nephrine n = 16 (1.02 ± 1.4 µg/kg per min); norepinephrine
n = 18 (0.93 ± 1.184 µg/kg per min); dobutamine n =1 3
(6.0 ± 3.1 µg/kg per min); dopamine n = 20 (7.5 ± 5.0 µg/kg
per min)]. Twenty-six (79%) patients had native valve endo-
carditis (NVE) and seven (21%) had prosthetic valve endo-
carditis (PVE). In NVE the aortic valve was infected in 14
patients and the mitral valve in nine patients and both the
aortic and the mitral valve were infected in three patients. In
PVE the aortic valve was involved in six patients and the mitral
valve in one patient. Six patients with PVE had a bioprosthe-
sis and one patient had a mechanical prosthesis.
Microbiological results
Staphylococcus aureus (one methicillin-resistant strain) was
identified as the most common infecting organism in 12
(36%) patients (nine patients with NVE and three patients
with PVE). Viridans streptococci were encountered in five
(15%) patients (all with NVE), enterococci in four (12%)
patients (three patients with NVE and one patient with PVE).
Corynebacterium and  Staphylococcus warneri were each
found in one patient. Culture-negative IE was observed in 10
(27%) patients (seven patients with NVE and three patients
with PVE). Cultures of tissue obtained at surgery (n = 4) or at
autopsy (n = 6) were negative in all cases. Six of the patients
with negative cultures had received prior antibiotic therapy for
14.7 ± 15 days. Duration of disease before ICU admission
tended to be shorter in patients with culture-negative IE
(median illness duration 5 versus 13 days, P = 0.12).
Echocardiography
The echocardiogram was indicative for IE in all patients.
Typical findings are presented in Figures 1 and 2. Diagnosis
of IE was established by transthoracic study in 11 (33%)
patients and by transesophageal echocardiography in 22
(67%) patients. However in eight patients with an already
diagnostic transthoracic echocardiography, additional trans-
esophageal echocardiography was required for complete
assessment of extent of disease. Valvular vegetations were
seen in 25 (76%) patients, of whom 13 had aortic valve
involvement, 10 had mitral valve involvement and two had
combined aortic and mitral valve involvement. Trans-
esophageal findings missed by the initial transthoracic
echocardiography were valvular vegetations in 17 cases, flail
leaflets in two cases, and abscess formation in 10 cases.
Maximum diameter of the vegetation was >10 mm in
12 patients and <10 mm in 13 patients. There was a trend
towards a higher risk of subsequent systemic embolism in
patients with a vegetation size >10 mm (OR 5.5, 95% CI
0.96–31.43, P = 0.07). Cavities indicating abscess formation
were found in 18 patients (54%). Severe valvular regurgita-
tion (grade 3 or 4) of the aortic valve (n = 13) and/or mitral
valve (n = 8) was present in 20 (60%) patients.
Clinical course
All patients received antibiotics according to microbiological
findings or when culture negative according to standard
antibiotic regimens using either penicillin G, flucloxacillin or
vancomycin/teicoplanin in combination with aminoglycosides.
Overall 20 (60%) patients, 14 with NVE and six patients with
PVE, underwent valvular surgery 6 ± 9 (range: 0–38) days
after admission to the ICU. Main indications for surgery were
congestive heart failure in 13 cases, uncontrolled sepsis in
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Figure 1
Transesophageal long axis view in a patient with severe heart failure
and mitral incompetence showing a large vegetation (at arrows)
attached to the posterior mitral valve leaflet. LA, left atrium; LV, left
ventricle; MV, mitral valve; Veg, vegetation.
Table 1
Characteristics of patients on admission
Male/female 26/7
Age (years) 59.1 ± 12.7 (28–79)
APACHE III score (points) 75 ± 31 (31–150)
Temperature (°C) 37.2 ± 1.3 (34.4–39.7)
Platelets (×109/l) 148 ± 101 (32–395)
WBC (×109/l) 16.8 ± 9.3 (3.3–48.0)
Heart rate (bpm) 106 ± 24 (30–150)
C-reactive protein (mg/dl) 11.1 ± 7.4 (0.5–29.2)
Glasgow coma score 12 ± 3 (3–15)
Illness duration (days) 22 ± 26 (0–109)
AV-block II or III 6 (18)
Acute renal failure 13 (39)
Multiorgan failure 21 (64)
Continuous variables are presented as mean ± SD (range) and
categorical measures are presented as n (%). AV, atrioventricular;
WBC, white blood cell count.four cases and recurrent embolism in three cases. Main
reasons for deferring surgery were a questionable neurologi-
cal outcome in three patients and a severe comorbid status in
two patients. Two patients were clinically stable and were
judged not to require emergency surgery. Six other patients
died before surgery could be performed. Clinical and labora-
tory characteristics of patients undergoing surgical or non-
surgical treatment are compared in Table 2. No significant
differences and only a trend towards a higher APACHE III
score in non-surgical patients were observed. Surgical treat-
ment comprised isolated aortic valve replacement in nine
patients, isolated mitral valve replacement in six patients and
a combined valvular procedure in five patients. For aortic
valve replacement a bioprosthesis was used in seven
patients, a homograft in six patients and mechanical prosthe-
sis in one patient. Mitral valve surgery included mitral valvular
repair in six patients and mitral valve replacement with a
mechanical prosthesis or a bioprosthesis in three and two
patients, respectively.
Prognostic factors
Eighteen (54%) patients died during the hospital stay, 7/20
(35%) after valvular surgery and 11/13 (84%) in the med-
ically treated group. By univariate analysis significant associa-
tions between in-patient mortality and a white blood cell
count (WBC) of >15 ×109/l and the presence of acute renal
failure were observed. Multivariate analysis identified acute
renal failure on admission as the single independent risk
factor for death (Table 3). Seven patients died as a result of
cardiogenic shock and seven from septic shock. One patient
in the surgical group and one in the non-surgical group died
as a result of uncontrolled bleeding. Among the surviving
patients, two (one conservatively treated and one surgically
treated patient) had a Glasgow Coma Score of <14 at trans-
fer out of the ICU.
Discussion
The study presented here examined the clinical course and
prognosis for patients requiring admission to an ICU because
of IE. To our knowledge it represents the first systematic
analysis of this small but important subset of ICU patients
and highlights the serious prognosis of patients with a com-
plicated course of IE.
Cardiogenic and septic shock were the main reasons for
intensive care treatment. Male preponderance and age distri-
bution in this study were comparable to non-ICU series [2].
All patients in this study had left-sided valvular endocarditis
and the aortic valve was most commonly involved. PVE was
frequent, which might be explained by the location of three of
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Figure 2
Transesophageal long axis view in a patient with sepsis demonstrating
a large vegetation attached to the anterior mitral valve leaflet and an
echo-free space in the mitral valve annulus infiltrating the surrounding
myocardium consistent with the presence of an abscess. Abscess
formation was confirmed at surgery. LA, left atrium; LV, left ventricle;
MV, mitral valve; Veg, vegetation.
Table 2
Characteristics of patients with and without surgical treatment
Without surgery  With surgery 
Parameter (n = 13) (n = 20) P-value
Age (yr) 60.4 ± 13.3 58.4 ± 12.6 0.55
APACHE III score (points) 84 ± 34 69 ± 30 0.17
Temperature (°C) 37.1 ± 1.2 37.2 ± 1.5 0.78
Platelets (×109/l) 162 ± 116 139 ± 92 0.67
WBC (×109/l) 18.7 ± 12.8 15.6 ± 6.2 0.27
Heart rate (bpm) 106 ± 34 106 ± 17 0.74
C-reactive protein (mg/dl) 13.7 ± 7.4 9.4 ± 7.1 0.06
Illness duration (days) 18.1 ± 24.2 24.5 ± 28.4 0.45
AV-block II or III 2 4 0.81
Acute renal failure 6 7 0.47
Catecholamine therapy 9 15 1.00
Mechanical ventilation 12 14 0.15
Congestive heart failure 8 13 0.56
Septic shock 1 6 0.14
Multiorgan failure 11 10 0.07
CPR before admission 3 0 0.06
Aortic valve endocarditis 9 14 0.96
Mitral valve endocarditis 6 8 0.73
Native valve endocarditis 11 14 0.30
Prosthetic valve endocarditis 2 5 0.42
Continuous variables are presented as median ± SD (range), and
categorical measures are presented as n. AV, atrioventricular; CPR,
cardiopulmonary resuscitation; WBC, white blood cell count.the participating ICUs in a university hospital environment.
Surprisingly, no cases of right-sided IE were observed, which
is reported to be frequent in intravenous drug abusers [10].
The two patients with a history of intravenous drug abuse
included in the series had left cardiac involvement.
In all the patients in the study with positive blood culture
Gram-positive strains were present and Staphylococcus
aureus was identified as the most prevalent pathogen. The
proportion of culture-negative endocarditis in this cohort was
slightly higher than in previous reports [2], which may be
explained by the high incidence of antimicrobial pretreatment
and by the fact that these patients tended to have a shorter
illness duration making a detailed microbiologic evaluation
more difficult. In a previous study, 62% of patients with
culture-negative endocarditis had received prior antibiotic
therapy compared to only 31% of patients with culture-posi-
tive endocarditis [11].
Previous studies also reported a worse prognosis in patients
with IE secondary to infection with certain microorganisms
such as Staphylococcus aureus [9]. The study reported here
failed to show an association between bacteriological find-
ings and outcome. It is likely that any differences in mortality
will diminish in the presence of a complicated clinical course
of the disease.
The study also highlights the usefulness of the trans-
esophageal echocardiography approach for diagnosis and
risk stratification of IE. Transesophageal echocardiography
was required in more than 90% of the patients, either to
ascertain the pending diagnosis or to delineate the full extent
of disease. Vegetations were seen by transthoracic or trans-
esophageal echocardiography in 79% of the patients. In line
with previous series, systemic embolism appeared to
increase by more than fivefold in patients with vegetations
>10 mm in size. Abscess formation was also a frequent
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Table 3
Risk factors for in-patient death
Parameter Survived (n = 15) Died (n = 18) UV (P-value) MV (P-value) OR (95%CI)
Age (yr) 56 ± 13 62 ± 12 0.36
Temperature (°C) 37.5 ± 1.2 36.9 ± 1.5 0.36
Platelets (×109/l) 153 ± 99 144 ± 106 0.80
Heart rate (bpm) 109 ± 16 104 ± 30 0.60
C-reactive protein (mg/dl) 11.7 ± 8.9 10.6 ± 6.2 0.37
Illness duration (days) 28 ± 31 18 ± 22 0.45
AV-block 1 5 0.18
Acute renal failure 3 10 0.03 0.04 5 (1.04–24.03)
Congestive heart failure 10 11 0.74
Septic shock  4 3 0.67
Systemic emboli 10 10 0.51
CPR before admission 0 3 0.23
Aortic valve endocarditis 9 14 0.44
Mitral valve endocarditis 7 7 0.65
Native valve endocarditis 11 14 1.00
Prosthetic valve endocarditis 3 4 1.00
Cavities on echo 6 10 0.37
Vegetation on echo 13 13 0.41
WBC >15×109/l 4 11 0.04 0.18 2.9 (0.60–54.0)
Staphylococcus aureus 7 5 0.26
Streptococcus viridans 2 3 0.68
Culture-negative endocarditis 5 5 1.0
Early appropriate antibiotics 10 8 0.2
Continuous variables are presented as median ± SD (range), and categorical measures are presented as n. AV, atrioventricular; CI, confidence
interval; CPR, cardiopulmonary resuscitation; MV, multivariate analysis; OR, odds ratio; UV, univariate analysis; WBC, white blood cell count.finding on transesophageal echocardiography in this cohort
of ICU patients.
The observed overall in-patient mortality of 54% in this series
is high, but cannot be compared with data obtained in other
series because the analysis here included only the patients
with severest IE, who required admission to an ICU. Multivari-
ate analysis showed that presence of acute renal failure on
admission was the single independent greatest risk factor for
a fatal outcome. More than half of the patients in the study
underwent successful surgical treatment. In other series,
which included patients with IE associated with severe heart
failure, in-patient mortality after surgery reached 41% [12,13].
Patients admitted to an ICU as a result of a complicated
course of IE, may frequently require acute cardiac surgery for
correction of massive valvular regurgitation or for prevention
of recurrent systemic embolism. Abscess drainage and/or
removal of prosthetic endovascular material may be neces-
sary for treatment of uncontrolled sepsis. Antibiotic pretreat-
ment lasting for several days before cardiac surgery is
recommended by some authors [12], but several of the
patients in this study had to be operated on immediately after
initiation of antibiotic therapy. Nevertheless, cardiac surgery is
often deferred in the setting of severe shock and/or of multi-
organ failure and patient transfer to a cardiac surgery facility
may be associated with additional risks. The decision whether
to perform acute surgery is particularly difficult in uncon-
scious or sedated patients with an uncertain neurologic
outcome. In the study series cardiac surgery was most often
deferred in these patients.
In conclusion, our results show that despite improvements in
diagnostic and surgical techniques, advances in antibiotic
therapy and optimized critical care, IE still involves a poor
prognosis once major complications such as heart failure,
septic shock or recurrent systemic embolism have developed.
Diagnostic work-up, including a complete transthoracic and
transesophageal study, must be performed immediately in
every patient admitted to an ICU with embolism, heart failure,
cardiogenic or septic shock of unknown cause, as the data
presented here suggest that prompt surgical intervention can
be life-saving in patients with IE despite the presence of
severe shock and the occurrence of multiorgan failure.
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